Plain-English translation of NCT06642610 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot study is testing a new approach to predict whether people with cystic fibrosis who have prediabetes will progress to diabetes. Researchers will use data from continuous glucose monitors (small wearable devices that track blood sugar throughout the day) to build a prediction model. The goal is to help doctors identify which patients are most at risk, so they can intervene earlier.
Cystic fibrosis can affect how the body processes blood sugar, sometimes leading to diabetes. Right now, doctors don't have a good way to predict who will develop this complication. This study aims to create a tool based on real-world glucose patterns that could help catch diabetes earlier and prevent serious health problems.
You likely qualify if…
You likely don't qualify if…
Participants will wear a continuous glucose monitor (a small sensor attached to the skin) that tracks blood sugar levels throughout the day and wirelessly sends data to a smartphone app. Depending on your group, you may also complete blood tests to confirm your diabetes status. The study team will collect your glucose data over time to develop their prediction model. Most visits will involve wearing the monitor and checking in with the research team periodically.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
Indiana University
Enrollment target
~70 participants
Started
June 2025
Primary completion
June 2026
Age range
12 Years – 55 Years
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Eslam Montaser, PhD
Indiana University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.